Essential Partners’s Nuvalent NUVL Stock Holding History

Essential Partners’s Portfolio NUVL Stock Details NUVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$410	Hold	4	–	–	﹤0.01%	2491
2025 Q4	$402	Hold	4	–	–	﹤0.01%	2276
2025 Q3	$346	Buy	4 +2	+100%	+$158	﹤0.01%	2284
2025 Q2	$153	Buy	+2	New	+$146	﹤0.01%	2005

Other funds holding NUVL

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Essential Partners's NUVL Position: Q1 2026 in Review

Essential Partners held its Nuvalent (NUVL) position steady in Q1 2026 at 4 shares worth $410. The position accounts for ﹤0.01% of the portfolio, ranked #2491.

Essential Partners first reported a position in NUVL in Q2 2025 and has held it in 4 quarters since. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

Essential Partners held 4 shares of Nuvalent worth $410 as of Q1 2026.
Essential Partners left its Nuvalent share count unchanged in Q1 2026.
Nuvalent made up ﹤0.01% of Essential Partners's portfolio in Q1 2026, its #2491 holding.
Essential Partners first reported a position in Nuvalent in Q2 2025 and has held it in 4 quarters since.
263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on Essential Partners's 13F filing for Q1 2026, filed 21 May 2026.